Research / OESX / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-24-122360 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
64.69% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.03% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
2.57% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-5.95% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
77.61% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
23.10% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-16.90% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.69% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.80% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 15 states History building
Dec 31, 2022 0/8 normalized Level 3 Mar 31, 2023 0/8 normalized Level 3 Jun 30, 2023 0/8 normalized Level 3 Sep 30, 2023 0/8 normalized Level 3 Dec 31, 2023 0/9 normalized Level 3 Mar 31, 2024 0/9 normalized Level 3 Jun 30, 2024 0/9 normalized Level 3 Sep 30, 2024 0/9 normalized Level 3 Dec 31, 2024 7/8 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 8/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 3 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 67.94%
Current 64.69%
Delta -3.25% Capex Intensity Decreased
Previous 0.12%
Current 0.03%
Delta -0.09% Cash Generation Increased
Previous -14.88%
Current 2.57%
Delta 17.45% Growth Decreased
Previous 13.02%
Current -5.95%
Delta -18.97% Inventory Pressure Decreased
Previous 79.67%
Current 77.61%
Delta -2.06% Margin Increased
Previous 21.60%
Current 23.10%
Delta 1.50% Profitability Increased
Previous -17.24%
Current -16.90%
Delta 0.34% R And D Intensity Increased
Previous 1.33%
Current 1.69%
Delta 0.37% Sbc Intensity Increased
Previous 1.48%
Current 1.80%
Delta 0.32% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.